Rock Weekly: Deconstructing the Fitbit IPO
May 11, 2015
Digital health IPOs are finally heating up. Off the heels of another filing last week, both Fitbit and Evolent Health sent off S-1s to the SEC—each for $100M. No time to read all 130K+ words? Enjoy the tl;dr version of Fitbit’s filing we wrote just for you.
What’s next for these soon-to-be-public companies? The activity tracking pioneer will be defending against the Apple Watch, while, perhaps, population health management company Evolent can stem the rising tide of ER visits the ACA has not prevented.
Deconstructing The Fitbit S-1
Rock Health blog
Washington’s Interest In Precision Drugs Is Innovation, Not Cost
The Revolution Will Be Digitized
The Washington Post
White House Moves To Fix Two Key Consumer Complaints About ACA
The New York Times
Fighting Epidemics With Math
Apple Has Plans For Your DNA
Dr. Karen Desalvo To Leave ONC If Confirmed For New HHS Post
Rock Health In The News
Tech Companies See Market Opportunity In Healthcare Innovation
|InDemand Interpreting||$4M||Health Enterprise Partners, Providence Ventures||FinSMEs|
|Sherpaa||$2.25M||O’Reilly Alpha Tech Ventures, First Round Capital, Collaborative Fund||MobiHealthNews|
Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.
Get our weekly curated take on everything happening in digital health. Sign up for the Rock Weekly.
[gravityform id=”1″ name=”Stay in touch” title=”false” description=”false” ajax=”true”]